PCSK9 Antibodies for the Treatment of Hypercholesterolemia

The serine protease proprotein convertase subtilisin/kexin type 9 (PCSK9) binds to the low-density lipoprotein (LDL) receptor (LDLR) and directs it to lysosomes for intracellular degradation. This results in decreased numbers of LDLR available on the hepatic cell surface to bind LDL particles and re...

Descripción completa

Detalles Bibliográficos
Autores principales: Gouni-Berthold, Ioanna, Berthold, Heiner K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2014
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276981/
https://www.ncbi.nlm.nih.gov/pubmed/25470376
http://dx.doi.org/10.3390/nu6125517

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4276981/
https://www.ncbi.nlm.nih.gov/pubmed/25470376
http://dx.doi.org/10.3390/nu6125517

Ejemplares similares